Acer Therapeutics Inc
Biotechnology
Healthcare
ACER
16.09 M shares
NASDAQ US
traded
16 Mar 2023
listed
yes
open
1.55
52 week high
4.15
high
1.66
52 week low
1.33
low
1.55
growth
-45.99 %
previous Close
1.60
P/E ratio
market cap
37.29 M
div yield
0
usd
Sep 2022
qoq
revenue
0.00 %
net incoming
-5.01 M
-87.73 %
eps
0.00 %
-82.35 %
eps surprise
54.41 %
net profit margin
-500694500.00 %
0.00 %
operating incoming
-5.24 M
25.84 %
net change in cash
-8.09 M
-27.82 %
cash on hand
6.38 M
-55.92 %
cost of revenue
0.00 %
top top